IBMS/ECTS 2001 - PROGRAM and ABSTRACTS

PLENARY SESSION 6

CANCER AND METABOLIC BONE DISEASES OTHER THAN OSTEOPOROSIS

Chairs: Jean-Jacques Body (Brussels/Belgium),
Socrates Papapoulos (Leiden/The Netherlands)

Saturday, June 9, 2001
08:30 - 09:30 Auditorium

IN12
Cancer and Bone
Theresa Guise (San Antonio, TX/USA)
IN13
Paget’s Disease from a Genetic Perspective
Wim Van Hul (Antwerp/Belgium)

[Saturday at a Glance] [Contents page]


ORAL PRESENTATIONS 6

CANCER AND METABOLIC BONE DISEASES OTHER THAN OSTEOPOROSIS

Chairs: Jean-Jacques Body (Brussels/Belgium),
Socrates Papapoulos (Leiden/The Netherlands)

Saturday, June 9, 2001
09:30 - 11:10 Auditorium

The abstract text of oral presentations (prefix OR) can be found in the Abstracts section. Click on the Abstract number

09:30 OR45
INTERACTIONS BETWEEN MULTIPLE MYELOMA AND BONE CELLS FORMING A VICIOUS CYCLE
M. Abe, K. Hiura, J. Wilde, S. Kido, S. Hashimoto, S. Ozaki, K. Moriyama, D. Inoue, T. Matsumoto*
Tokushima University, Tokushima, Japan
09:42 OR46
THE TRANSCRIPTION FACTOR NF-KB PLAYS A CRITICAL ROLE IN IGF-PROMOTED BONE METASTASIS OF BREAST CANCER
T. Hiraga*, A. Myoui, P. J. Williams, G. R. Mundy, T. Yoneda
Dept. Biochemistry and Orthopedics, Osaka Univ., Osaka, Japan; Div. Endocrinol., Univ. TX Hlth. Sci. Ctr., San Antonio, TX, USA
09:54 OR47
IN VIVO OSTEOCLASTOGENIC EFFECTS OF THE C-C CHEMOKINE MACROPHAGE INFLAMMATORY PROTEIN-1 ALPHA
B. O. Oyajobi*, P. J. Williams, D. Pulkrabek, G. Franchin, B. Sherry, G. R. Mundy
Medicine/Endocrinology, University of Texas Health Science Center at San Antonio, San Antonio, TX, USA; The Picower Institute for Medical Research, Manhasset, NY, USA
10:06 OR48
OSTEOPROTEGERIN INHIBITS THE DEVELOPMENT OF OSTEOLYTIC BONE DISEASE IN MULTIPLE MYELOMA
P. I. Croucher*, C. M. Shipman, M. Perry, J. Lippitt, K. Asosingh, E. J. R. van Beek, B. Van Camp, R. G. G. Russell, C. Dunstan, K. Vanderkerken
University of Sheffield Medical School, Sheffield, UK; University of Bristol, Bristol, UK; Free University, Brussels, Belgium; Royal Hallamshire Hospital, Sheffield, UK; Amgen Inc., Thousand Oaks, CA, USA
10:18 OR49
TRANSFORMING GROWTH FACTOR-b (TGF-b) STIMULATES TUMOR PARATHYROID HORMONE-RELATED PROTEIN (PTHrP) PRODUCTION VIA MITOGEN ACTIVATED PROTEIN (MAP) KINASE PATHWAYS IN A CELL-SPECIFIC MANNER
S. Kakonen*, M. Neal, J. M. Chirgwin, K. S. Selander, B. G. Grubbs, J. J. Yin, T. A. Guise
Medicine/Endocrinology, University of Texas Health Science Center, San Antonio, USA; University of Alabama, Birmingham, USA
10:30 OR50
CHEMOTHERAPEUTIC DRUGS SENSITISE OSTEOGENIC SARCOMA CELLS BUT NOT NORMAL HUMAN BONE CELLS TO TRAIL-MEDIATED APOPTOSIS
G. J. Atkins*, A. Evdokiou, S. Bouralexis, F. Chai, S. Hay, M. T. Clayer, D. M. Findlay
Dept Orthopaedics, Royal Adelaide Hospital, The University of Adelaide, Adelaide, Australia; Dept Medicine, Dept Orthopaedics, The Queen Elizabeth Hospital, The University of Adelaide, Woodville, Australia
10:42 OR51
INACTIVATION OF MENIN, A SMAD3-INTERACTING PROTEIN, BLOCKS TGFb SIGNALING
L. Canaff*, H. Kaji, J-J. Lebrun, D. Goltzman, G. N. Hendy
Department of Medicine, McGill University, Montreal, Qc, Canada; Department of Physiology, McGill University, Montreal, Qc, Canada; Department of Human Genetics, McGill University, Montreal, Qc, Canada
10:54 OR52
A GENOME-WIDE SEARCH IN FAMILIAL PAGET'S DISEASE OF BONE
L. J. Hocking*, C. A. Herbert, R. K. Nicholls, S. T. Bennett, T. Cundy, G. C. Nicholson, W. van Hul, W. Wuyts, S. H. Ralston
Department of Medicine and Therapeutics, University of Aberdeen, UK; Oxagen, Abingdon, UK; University of Auckland, New Zealand; University of Melbourne, Australia; University of Antwerp, Belgium

[Saturday at a Glance] [Contents page]